1078 companies

Strategy

Market Cap: US$94.7b

Operates as a bitcoin treasury company in the United States, Europe, the Middle East, Africa, and internationally.

MSTR

US$327.79

7D

-0.6%

1Y

143.7%

Trade Desk

Market Cap: US$22.1b

Operates as a technology company in the United States and internationally.

TTD

US$45.15

7D

-13.2%

1Y

-57.2%

Rubrik

Market Cap: US$14.7b

Provides data security solutions to individuals and businesses worldwide.

RBRK

US$75.60

7D

-20.9%

1Y

140.9%

Duolingo

Market Cap: US$14.1b

Operates as a mobile learning platform in the United States, the United Kingdom, and internationally.

DUOL

US$285.11

7D

5.1%

1Y

21.8%

Summit Therapeutics

Market Cap: US$14.1b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

SMMT

US$18.94

7D

-2.6%

1Y

-35.8%

On Holding

Market Cap: US$14.0b

Engages in the development and distribution of sports products worldwide.

ONON

US$42.67

7D

-5.6%

1Y

-14.5%

QXO

Market Cap: US$14.0b

Distributes roofing, waterproofing, and other building products in the United States.

QXO

US$21.23

7D

-3.3%

1Y

54.4%

Aurora Innovation

Market Cap: US$10.5b

Operates as a self-driving technology company in the United States.

AUR

US$5.89

7D

2.2%

1Y

20.6%

U-Haul Holding

Market Cap: US$10.4b

Operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.

UHAL

US$56.33

7D

-2.7%

1Y

-22.9%

BioMarin Pharmaceutical

Market Cap: US$10.4b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$53.14

7D

-5.7%

1Y

-23.9%

Moderna

Market Cap: US$9.1b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

MRNA

US$23.88

7D

-3.8%

1Y

-65.5%

Primo Brands

Market Cap: US$9.0b

Operates as a branded beverage company in North America.

PRMB

US$22.43

7D

-8.6%

1Y

-7.6%

Chime Financial

Market Cap: US$8.8b

A financial technology company, provides digital consumer banking and payment solutions.

CHYM

US$23.24

7D

-4.9%

1Y

n/a

Revolution Medicines

Market Cap: US$8.7b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

RVMD

US$46.20

7D

12.5%

1Y

3.7%

Liberty Broadband

Market Cap: US$8.7b

Engages in a range of communications businesses in the United States.

LBRD.K

US$59.96

7D

-1.0%

1Y

-3.0%

Birkenstock Holding

Market Cap: US$8.5b

Engages in the manufacture and sale of footwear products.

BIRK

US$46.09

7D

-5.7%

1Y

-4.5%

Corcept Therapeutics

Market Cap: US$7.7b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

CORT

US$69.53

7D

-2.4%

1Y

80.7%

VinFast Auto

Market Cap: US$7.7b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

VFS

US$3.24

7D

0.6%

1Y

-18.0%

Avidity Biosciences

Market Cap: US$6.4b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

RNA

US$40.19

7D

-16.4%

1Y

-3.7%

Repligen

Market Cap: US$6.4b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

RGEN

US$113.74

7D

-5.8%

1Y

-18.8%

Cytokinetics

Market Cap: US$6.1b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

CYTK

US$49.44

7D

-5.1%

1Y

-12.9%

Legend Biotech

Market Cap: US$6.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$33.88

7D

-2.1%

1Y

-33.9%

Axsome Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

AXSM

US$116.78

7D

-9.7%

1Y

26.4%

Clearwater Analytics Holdings

Market Cap: US$5.9b

Develops and provides a Software-as-a-Service (SaaS) solution for automated investment data aggregation, reconciliation, accounting, and reporting services to insurers, investment managers, corporations, institutional investors, and government entities in the United States and internationally.

CWAN

US$19.36

7D

-5.1%

1Y

-21.0%

Bath & Body Works

Market Cap: US$5.6b

Operates as a specialty retailer of home fragrance, personal and body care, soaps, and sanitizer products.

BBWI

US$26.46

7D

-7.1%

1Y

-8.5%

Caesars Entertainment

Market Cap: US$5.2b

Operates as a gaming and hospitality company.

CZR

US$25.90

7D

-1.8%

1Y

-34.3%

Glaukos

Market Cap: US$4.7b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

GKOS

US$80.64

7D

-12.2%

1Y

-35.1%

OneStream

Market Cap: US$4.6b

OneStream, Inc. delivers a unified, AI-enabled, and extensible software platform in the United States and internationally.

OS

US$18.53

7D

-8.2%

1Y

-39.1%

Alkermes

Market Cap: US$4.5b

A biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

ALKS

US$26.52

7D

-6.8%

1Y

-4.7%

Arcellx

Market Cap: US$4.2b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

ACLX

US$75.20

7D

5.8%

1Y

-2.4%

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

PCVX

US$31.00

7D

-4.4%

1Y

-72.9%

Arrowhead Pharmaceuticals

Market Cap: US$4.1b

Develops medicines for the treatment of intractable diseases in the United States.

ARWR

US$28.67

7D

5.5%

1Y

40.2%

ADMA Biologics

Market Cap: US$3.8b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$15.30

7D

-6.8%

1Y

-15.9%

Vertex

Market Cap: US$3.8b

Provides enterprise tax technology solutions for retail trade, wholesale trade, and manufacturing industries in the United States and internationally.

VERX

US$24.05

7D

-7.3%

1Y

-33.9%

Globalstar

Market Cap: US$3.8b

Provides mobile satellite services in the United States, Canada, Europe, Central and South America, and internationally.

GSAT

US$31.17

7D

-17.8%

1Y

73.2%

Accelerant Holdings

Market Cap: US$3.8b

Accelerant Holdings, together with its subsidiaries, operate a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners.

ARX

US$17.57

7D

-13.1%

1Y

n/a

Page 1 of 30